Found: 21
Select item for more details and to access through your institution.
Systemic Therapy for Psoriasis and the Risk of Herpes Zoster: A 500,000 Person-year Study.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Systemic Therapy for Psoriasis and the Risk of Herpes Zoster A 500000 Person-year Study.
- Published in:
- JAMA Dermatology, 2015, v. 151, n. 5, p. 533, doi. 10.1001/jamadermatol.2014.4956
- By:
- Publication type:
- Article
Rate of breast biopsy referrals in female BRCA mutation carriers aged 50 years or more: a retrospective comparative study and matched analysis.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 193, n. 2, p. 507, doi. 10.1007/s10549-021-06498-9
- By:
- Publication type:
- Article
Tirzepatide versus semaglutide for weight loss in patients with type 2 diabetes mellitus: A value for money analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 4, p. 961, doi. 10.1111/dom.14940
- By:
- Publication type:
- Article
Second-Line Treatment of Her2-Positive Metastatic Breast Cancer: Trastuzumab beyond Progression or Lapatinib? A Population Based Cohort Study.
- Published in:
- PLoS ONE, 2015, v. 10, n. 9, p. 1, doi. 10.1371/journal.pone.0138229
- By:
- Publication type:
- Article
Impact of a financial risk-sharing scheme on budget-impact estimations: a game-theoretic approach.
- Published in:
- European Journal of Health Economics, 2014, v. 15, n. 5, p. 553, doi. 10.1007/s10198-013-0544-6
- By:
- Publication type:
- Article
Can Consultation by a Clinical Pharmacist Prevent Morbidity and Mortality in Patients Undergoing Bariatric Surgery?
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 2, p. 310, doi. 10.3390/jcm13020310
- By:
- Publication type:
- Article
Nivolumab in Non-Small Cell Lung Cancer: Real World Long-Term Survival Results and Blood-Based Efficacy Biomarkers.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.625668
- By:
- Publication type:
- Article
Correction to: Sodium-Glucose Cotransporter 2 Inhibitors for Prevention of Heart Failure Events in Patients with Type 2 Diabetes Mellitus: A Cost Per Outcome Analysis.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Sodium-Glucose Cotransporter 2 Inhibitors for Prevention of Heart Failure Events in Patients with Type 2 Diabetes Mellitus: A Cost Per Outcome Analysis.
- Published in:
- Clinical Drug Investigation, 2020, v. 40, n. 7, p. 665, doi. 10.1007/s40261-020-00929-z
- By:
- Publication type:
- Article
Effect of Dapagliflozin Versus Empagliflozin on Cardiovascular Death in Patients with Heart Failure Across the Spectrum of Ejection Fraction: Cost per Outcome Analysis.
- Published in:
- American Journal of Cardiovascular Drugs, 2023, v. 23, n. 3, p. 323, doi. 10.1007/s40256-023-00578-5
- By:
- Publication type:
- Article
Aspirin with Low-Dose Ticagrelor or with Low-Dose Rivaroxaban for Secondary Prevention: A Cost per Outcome Analysis.
- Published in:
- American Journal of Cardiovascular Drugs, 2022, v. 22, n. 6, p. 677, doi. 10.1007/s40256-022-00543-8
- By:
- Publication type:
- Article
Dapagliflozin Versus Sacubitril–Valsartan to Improve Outcomes of Patients with Reduced Ejection Fraction and Diabetes Mellitus.
- Published in:
- American Journal of Cardiovascular Drugs, 2022, v. 22, n. 3, p. 325, doi. 10.1007/s40256-021-00506-5
- By:
- Publication type:
- Article
Impact of flash glucose monitoring on glucose control and hospitalization in type 1 diabetes: A nationwide cohort study.
- Published in:
- Diabetes/Metabolism Research & Reviews, 2021, v. 37, n. 1, p. 1, doi. 10.1002/dmrr.3355
- By:
- Publication type:
- Article
Dapagliflozin versus empagliflozin in patients with chronic kidney disease.
- Published in:
- Frontiers in Pharmacology, 2023, v. 14, p. 01, doi. 10.3389/fphar.2023.1227199
- By:
- Publication type:
- Article
Ethnicity, recurrence score distribution, and clinical outcomes in ER + HER2‐negative breast cancer patients in Israel: A registry analysis.
- Published in:
- Breast Journal, 2020, v. 26, n. 10, p. 2096, doi. 10.1111/tbj.13870
- By:
- Publication type:
- Article
The 'real-life' impact of adding bevacizumab to first-line therapy in metastatic colorectal cancer patients: A large Israeli retrospective cohort study.
- Published in:
- Acta Oncologica, 2015, v. 54, n. 2, p. 164, doi. 10.3109/0284186X.2014.958532
- By:
- Publication type:
- Article
Arterial and Venous Thromboembolism in ALK-Rearrangement-Positive Non-small Cell Lung Cancer: A Population-Based Cohort Study.
- Published in:
- Oncologist, 2023, v. 28, n. 6, p. e391, doi. 10.1093/oncolo/oyad061
- By:
- Publication type:
- Article
Bevacizumab for Metastatic Colorectal Cancer: A Global Cost-Effectiveness Analysis.
- Published in:
- Oncologist, 2017, v. 22, n. 6, p. 694, doi. 10.1634/theoncologist.2016-0455
- By:
- Publication type:
- Article
Liraglutide versus semaglutide for weight reduction—a cost needed to treat analysis.
- Published in:
- Obesity (19307381), 2023, v. 31, n. 6, p. 1510, doi. 10.1002/oby.23752
- By:
- Publication type:
- Article
Effectiveness of dasabuvir/ombitasvir/paritaprevir/ritonavir for hepatitis C virus in clinical practice: A population-based observational study.
- Published in:
- PLoS ONE, 2017, v. 12, n. 7, p. 1, doi. 10.1371/journal.pone.0176858
- By:
- Publication type:
- Article